APA (7th ed.) Citation

Toshinori Shirata, Shinji Yano, Keisuke Noto, Muneaki Kanno, & Akihito Suzuki. (2023). Jitteriness/anxiety syndrome caused by coadministration of celecoxib, a selective COX‐2 inhibitor, with escitalopram and trazodone in a patient with depression and spondylolisthesis. Wiley.

Chicago Style (17th ed.) Citation

Toshinori Shirata, Shinji Yano, Keisuke Noto, Muneaki Kanno, and Akihito Suzuki. Jitteriness/anxiety Syndrome Caused by Coadministration of Celecoxib, a Selective COX‐2 Inhibitor, with Escitalopram and Trazodone in a Patient with Depression and Spondylolisthesis. Wiley, 2023.

MLA (9th ed.) Citation

Toshinori Shirata, et al. Jitteriness/anxiety Syndrome Caused by Coadministration of Celecoxib, a Selective COX‐2 Inhibitor, with Escitalopram and Trazodone in a Patient with Depression and Spondylolisthesis. Wiley, 2023.